Navigation Links
,,Alternative Therapy in HIV Patients

As more HIV-infected patients turn to complementary and alternative medicine, researchers have set out to determine the prevalence and factors associated with such use.

In this study, researchers evaluated CAM use among nearly 3,000 patients enrolled in the HIV Cost and Services Utilization Study. Using this sample of patients who received conventional HIV care, researchers determined demographic and clinical characteristics of people with HIV. Approximately six months later, the use of CAM was determined during a follow-up// survey..
Researchers used data from interviews and surveys to determine the prevalence of CAM use, CAM use with potential for adverse effects, and CAM use as a substitute for conventional HIV therapy.
Results show 53 percent of patients reported using at least one type of CAM during the course of the study. The four most commonly used methods were relaxation, spiritual healing, self-help and herbal medicine. More than one-fourth of the patients used CAM with the potential for side effects and 3 percent reported using CAM in lieu of conventional HIV therapy. More than one-half of the patients using CAM had not discussed it with their health care providers. Findings from the study show HIV-infected patients who desired medical information and involvement in medical decision-making were most likely to use CAM. Researchers suggest a need for a health care setting that encourages open discussion between health care providers and patients. They say, "Improved physician understanding about patients' need for control over their own health care and the benefits and risks of CAM in HIV care may open channels of communication."

Researchers conclude that with one quarter of HIV-infected patients using CAM at the risk of potential side affects, physicians should openly ask their patients about such use. They suggest displaying a nonjudgmental attitude toward CAM may encourage patients to accurately report their use , thereby preventing unnecessary adverse effects.
'"/>




Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Consensus on "Combination Therapy" for Breast Cancer
3. Gene Therapy shows promise in treating Hemophilia
4. "Make AIDS Therapy affordable" - Physicians demand
5. Hormone replacement Therapy a headache
6. Simple Therapy
7. Therapy for stopping the spread of cancer cells
8. Gene Therapy Destroys Pancreatic Cancer Cells
9. Letrozole Beats Tamoxifen in Breast Cancer Therapy
10. Garlic Supplements Impede HIV Therapy
11. Gene Therapy For Cystic Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/22/2017)... ... September 22, 2017 , ... Silicon Valley ... even on the go. Their electric toothbrushes aggressively attack oral bacteria by reducing ... sanitizing technology. Combining leading edge Enke technology with a premium timeless design, they ...
(Date:9/22/2017)... ... September 22, 2017 , ... “Letters From Home”: a moving ... lost, have value to God. “Letters From Home” is the creation of published author, ... the President’s Cabinet of Jerry Savelle Ministries International, who has traveled and ministered on ...
(Date:9/22/2017)... ... September 22, 2017 , ... ... and create life. Although frozen embryos have a slight statistical advantage for live ... freezing is a wonderful opportunity for women undergoing medical treatment or who are ...
(Date:9/21/2017)... ... 21, 2017 , ... With ProSlideshow Portrait from Pixel Film Studios creating a ... select from up to two layers of subject matter along with fully customizable backdrop ... Final Cut Pro X. , With ProSlideshow Portrait each user are given ...
(Date:9/21/2017)... ... 21, 2017 , ... Process Capability Indices for Medical Device ... ET, http://www.fdanews.com/processcapabilityindices      , Quality in device manufacturing is ... Quality System Regulation (§820.250), and Devicemakers find themselves staring at a warning letter. ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... ... ... – Monday, September 18 th .The Brain Tumor Foundation (BTF) begins ... the public.Where:  BTF,s Mobile MRI Unit – a ... Washington, D.C.What:BTF brings its nationwide initiative, the Road to Early Detection Sponsor-A-City ...
(Date:9/9/2017)... Lilly and Company (NYSE: LLY ) will ... an investigational, oral, first-in-class molecule for the acute treatment ... placebo in the Phase 3 SPARTAN study. Detailed results ... the International Headache Society (IHC) in Vancouver ... lasmiditan,s potential to reduce pain and provide freedom from ...
(Date:9/7/2017)... MIRAGE, Calif. , Sept. 7, 2017  For nearly two decades, ... service in the Assisted Reproduction Insurance industry. Today, New Life Agency announces ... fertility medications. ... http://pharmacarecard.com/ (PRNewsfoto/PharmaCareCard) ... ...
Breaking Medicine Technology: